Family SuppleMented pAtient monitoRing afTEr suRgery: A Pilot Trial
SMARTER
1 other identifier
interventional
1,395
1 country
1
Brief Summary
To develop an intervention to train family carers to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff. To evaluate the effect of this intervention on the frequency of documented vital signs for patients in the first three days after surgery in a stepped-wedge cluster trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 10, 2020
CompletedStudy Start
First participant enrolled
April 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2021
CompletedSeptember 9, 2022
February 1, 2022
6 months
April 7, 2020
September 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of documented vital signs for patients after surgery
To develop a training and support intervention, in accordance with the MRC complex intervention framework, to train family carers to perform and document basic vital signs, to supplement routine monitoring of patients by nursing staff, whilst they provide personal care to their relatives after surgery and to evaluate the effect of this intervention on frequency of documented vital signs for patients in the first three days after surgery in a stepped-wedge cluster trial (explanatory outcome).
72 hours
Secondary Outcomes (2)
Duration of hospital stay
30 days
All cause mortality at 30 days
30 days
Study Arms (2)
Baseline
NO INTERVENTIONDuring this baseline period, postoperative monitoring will be continued as normal by nursing and medical staff without intervention. No training of family members will take place
Intervention
ACTIVE COMPARATORFamily carers will be trained to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff.
Interventions
Intervention training sessions will last 30 minutes and will be held twice a day over a period of six months. Carers will be welcome to attend as often as they wish. Carers will be given practical training to assess the following vital signs: heart rate, respiratory rate, conscious level (AVPU scale) and arterial oxygen saturation (SpO2) in accordance with trial standard operating procedures. An important component of the training package will be ensuring carers know how to wash their hands before and after contact with their patients. The study team will ensure that handwashing facilities are available on the ward for use by carers. Carers will record vital signs on a basic observation chart every 4 hours after surgery. They will compare results with colour posters displayed throughout each ward, providing guidance on how and when to notify nursing staff of abnormal vital signs.
Eligibility Criteria
You may qualify if:
- Patients:
- Patients ≥5 years of age undergoing surgery at Mbale Regional Referral Hospital, who receive post-operative care in one of four main surgical wards, with a family carer prepared to participate in the trial intervention.
- Carers:
- All carers will be included in the trial if they feel they are capable of performing and documenting the basic vital signs provided they agree to participate in the trial.
- The ability to speak English, Luganda, Lugisu, Ateso or Lugwere
- The ability to read a digital clock (to measure vital signs)
- Numeracy sufficient to write numbers on the basic observation chart
You may not qualify if:
- Patients:
- Refusal of informed consent.
- Identification of potential participant \>24hours after operative procedure has taken place
- Carers:
- Refusal of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen Mary University of Londonlead
- Busitema Universitycollaborator
Study Sites (1)
Mbale Regional Referral Hospital
Mbale, Uganda
Related Publications (1)
Hewitt-Smith A, Bulamba F, Patel A, Nanimambi J, Adong LR, Emacu B, Kabaleta M, Khanyalano J, Maiga AH, Mugume C, Nakibuule J, Nandyose L, Sejja M, Weere W, Stephens T, Pearse RM. Family supplemented patient monitoring after surgery (SMARTER): a pilot stepped-wedge cluster-randomised trial. Br J Anaesth. 2024 Oct;133(4):846-852. doi: 10.1016/j.bja.2024.06.027. Epub 2024 Jul 27.
PMID: 39069451DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rupert Pearse, MD
Queen Mary University of London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2020
First Posted
April 10, 2020
Study Start
April 13, 2021
Primary Completion
October 12, 2021
Study Completion
November 12, 2021
Last Updated
September 9, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share